Neurology Alert – May 1, 2014
May 1, 2014
View Archives Issues
-
Hyperbaric Oxygen Therapy for Blast-related Postconcussion Syndrome: Does It Work?
This well-designed, randomized, controlled trial, which included a sham arm, showed no evidence for the efficacy of hyperbaric oxygen therapy to treat the symptomatic, cognitive, and behavioral sequelae of postconcussion syndrome in soldiers after combat-related mild traumatic brain injury. -
Baseline Impairments and Decline in Cognition in Early Parkinson’s Disease
The Montreal Cognitive Assessment and Mini-Mental Status Exam demonstrated baseline deficits in early Parkinsons disease. -
Sleeping Pills Increase Risk of Death
Chronic use of sleeping medications, particularly benzodiazepines, is associated with an increase in all-cause mortality, and should be avoided if at all possible. -
B-lymphocyte Targeted Therapies for MS — Paradoxical Effect of Atacicept
A Phase 2 trial of atacicept, a humanized recombinant protein that suppresses B cell function, demonstrated a negative impact on clinical disease activity in relapsing-remitting multiple sclerosis. -
Non-Oculopharyngeal Involvement in OPMD
Oculopharyngeal muscular dystrophy is a rare, autosomal dominant neuromuscular disorder that has recently been genetically defined and may be treatable with myoblast transplantation. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Blood Pressure Variability May Predict Poor Outcome After Intracerebral Hemorrhage -
Stroke Alert: A Review of Current Clinical Stroke Literature
Hemicraniectomy in Older Patients with Large Middle Cerebral Artery Infarcts Reduces Mortality